Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01134172 · ClinicalTrials.gov registry record
Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life
A clinical trial of Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 935
- Enrollment target
- 12
- Study locations
NCT01134172: Active study of Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01134172 is a study of Breast Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 935 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (67% lower). The trial reports 12 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01134172, a study of Breast Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 935 participants
- Enrollment target
- 12
- Study locations
Study Summary
The purpose of this study is to learn more about how being treated for breast cancer affects patients' employment, financial situation, and quality of life on a short-term basis and on a long term basis. Most studies of employment after breast cancer have focused on Caucasian women.This study will evaluate the impact of breast cancer on the lives of women from different ethnic groups.
Conditions Studied
Interventions
- BEHAVIORAL survey web-based or telephone interview
Study Locations (12)
New York
- Woodhull Medical and Mental Health Center - Brooklyn
- Memorial Sloan Kettering Commack - Commack
- Queens Medical Associates - Fresh Meadows
- Memorial Sloan Kettering Westchester - Harrison
- Memorial Sloan Kettering at Ralph Lauren - New York
- Memorial Sloan Kettering Cancer Center - New York
- Bellevue Hospital Center - New York
- New York Presbyterian Queens - Queens
- NYC Health & Hospitals /Lincoln Medical Center - The Bronx
- Memorial Sloan Kettering Nassau - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge - Basking Ridge
- Memorial Sloan Kettering Monmouth - Middletown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 935 participants |
| Start Date | 2010-05 |
| Est. Completion | 2026-05 |
What the registry record for NCT01134172 still lists
NCT01134172 is an observational study that tracks outcomes without assigning an intervention. The registered 935 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (67% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which survey web-based or telephone interview is the first listed.
NCT01134172 lists 12 locations in 2 states (New York, New Jersey).
Frequently Asked Questions
What is clinical trial NCT01134172 about?
NCT01134172 is a clinical study titled "Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life". The purpose of this study is to learn more about how being treated for breast cancer affects patients' employment, financial situation, and quality of life on a short-term basis and on a long term basis. Most studies of employment after breast cancer have focused on Caucasian women.This study will e...
What is the current status of trial NCT01134172?
This trial is currently active not recruiting. The enrollment target is 935 participants. The study started on 2010-05. Estimated completion is 2026-05.
What conditions does trial NCT01134172 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT01134172?
The interventions under investigation include: survey web-based or telephone interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT01134172?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01134172 being conducted?
This trial has 12 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01134172's enrollment target sits among peer trials
935 132nd of 1224 higher than 1,093 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05519007 · 936 participants · NA
Rate of Total Joint Infection 90-day After Surgery Following Irrigation With Next Science No-Rinse Solution vs SOC Alone
- NCT04626635 · 933 participants · Phase 1
A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers
- NCT03075696 · 940 participants · Phase 1
A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma
- NCT06855277 · 940 participants · Phase 3
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia